134 related articles for article (PubMed ID: 26896756)
21. Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice.
Kai Y; Hikita H; Tatsumi T; Nakabori T; Saito Y; Morishita N; Tanaka S; Nawa T; Oze T; Sakamori R; Yakushijin T; Hiramatsu N; Suemizu H; Takehara T
J Gastroenterol; 2015 Nov; 50(11):1145-51. PubMed ID: 26208695
[TBL] [Abstract][Full Text] [Related]
22. Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy.
Itakura J; Kurosaki M; Takada H; Nakakuki N; Matsuda S; Gondou K; Asano Y; Hattori N; Itakura Y; Tamaki N; Yasui Y; Suzuki S; Hosokawa T; Tsuchiya K; Nakanishi H; Takahashi Y; Maekawa S; Enomoto N; Izumi N
Hepatol Res; 2015 Oct; 45(10):E115-21. PubMed ID: 25564756
[TBL] [Abstract][Full Text] [Related]
23. Management of HCV patients in cases of direct-acting antiviral failure.
Hayes CN; Imamura M; Chayama K
Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):839-848. PubMed ID: 31392907
[No Abstract] [Full Text] [Related]
24. Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir.
Ramirez S; Mikkelsen LS; Gottwein JM; Bukh J
Gastroenterology; 2016 Nov; 151(5):973-985.e2. PubMed ID: 27453546
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort.
Shepherd SJ; Abdelrahman T; MacLean AR; Thomson EC; Aitken C; Gunson RN
J Clin Virol; 2015 Apr; 65():50-3. PubMed ID: 25766988
[TBL] [Abstract][Full Text] [Related]
26. Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.
Wilson EM; Kattakuzhy S; Sidharthan S; Sims Z; Tang L; McLaughlin M; Price A; Nelson A; Silk R; Gross C; Akoth E; Mo H; Subramanian GM; Pang PS; McHutchison JG; Osinusi A; Masur H; Kohli A; Kottilil S
Clin Infect Dis; 2016 Feb; 62(3):280-288. PubMed ID: 26521268
[TBL] [Abstract][Full Text] [Related]
27. Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy.
Wada N; Ikeda F; Mori C; Takaguchi K; Fujioka SI; Kobashi H; Morimoto Y; Kariyama K; Sakaguchi K; Hashimoto N; Moriya A; Kawaguchi M; Miyatake H; Hagihara H; Kubota J; Takayama H; Takeuchi Y; Yasunaka T; Takaki A; Iwasaki Y; Okada H
Acta Med Okayama; 2018 Aug; 72(4):401-406. PubMed ID: 30140089
[TBL] [Abstract][Full Text] [Related]
28. Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on the
McPhee F; Ueland J; Vellucci V; Bowden S; Sievert W; Zhou N
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718256
[TBL] [Abstract][Full Text] [Related]
29. Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan.
Igarashi A; Tang W; Guerra I; Marié L; Cure S; Lopresti M
Curr Med Res Opin; 2017 Jan; 33(1):11-21. PubMed ID: 27609424
[TBL] [Abstract][Full Text] [Related]
30. Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.
Akuta N; Sezaki H; Suzuki F; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
J Med Virol; 2017 Feb; 89(2):284-290. PubMed ID: 27357737
[TBL] [Abstract][Full Text] [Related]
31. Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection.
Morishita N; Hiramatsu N; Oze T; Urabe A; Tahata Y; Yamada R; Yakushijin T; Hosui A; Iio S; Yamada A; Hagiwara H; Mita E; Yamada Y; Ito T; Inada M; Katayama K; Yabuuchi I; Imai Y; Hikita H; Sakamori R; Yoshida Y; Tatsumi T; Hayashi N; Takehara T
Hepatol Res; 2017 Jul; 47(8):773-782. PubMed ID: 27593967
[TBL] [Abstract][Full Text] [Related]
32. A profiling study of a newly developed HCVcc strain PR63cc's sensitivity to direct-acting antivirals.
Tao W; Gan T; Lu J; Zhong J
Antiviral Res; 2017 Mar; 139():18-24. PubMed ID: 28025084
[TBL] [Abstract][Full Text] [Related]
33. Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection.
Bourlière M; Adhoute X; Ansaldi C; Oules V; Benali S; Portal I; Castellani P; Halfon P
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1483-94. PubMed ID: 26595560
[TBL] [Abstract][Full Text] [Related]
34. A genotype independent, full-genome reverse-transcription protocol for HCV genotyping and resistance testing.
Walker A; Bergmann M; Camdereli J; Kaiser R; Lübke N; Timm J
J Clin Virol; 2017 Jun; 91():42-48. PubMed ID: 28463753
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C Virus Genotype 5 Variability in Treatment-Naïve Patients in South Africa.
Maunye TK; Gededzha MP; Blackard JT; Rakgole JN; Selabe SG
Intervirology; 2023; 66(1):77-87. PubMed ID: 37231989
[TBL] [Abstract][Full Text] [Related]
36. The importance of resistance to direct antiviral drugs in HCV infection in clinical practice.
Sarrazin C
J Hepatol; 2016 Feb; 64(2):486-504. PubMed ID: 26409317
[TBL] [Abstract][Full Text] [Related]
37. Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants.
Okubo T; Atsukawa M; Tsubota A; Shimada N; Abe H; Yoshizawa K; Arai T; Nakagawa A; Itokawa N; Kondo C; Aizawa Y; Iwakiri K
Hepatol Res; 2017 Jun; 47(7):641-649. PubMed ID: 27487797
[TBL] [Abstract][Full Text] [Related]
38. Distribution of Primary Resistance Mutations in Saint Petersburg in Patients with Chronic Hepatitis C.
Valutite D; Ostankova Y; Semenov A; Lyalina L; Totolian A
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626210
[TBL] [Abstract][Full Text] [Related]
39. Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt.
Shoun AA; Abozahra R; Baraka K; Mehrez M; Abdelhamid SM
Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456731
[TBL] [Abstract][Full Text] [Related]
40. 5' UTR and NS5B-based genotyping of hepatitis C virus in patients from Damietta governorate, Egypt.
El-Tahan RR; Ghoneim AM; Zaghloul H
J Adv Res; 2018 Mar; 10():39-47. PubMed ID: 30046475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
